Histamine-releasing factor in severe asthma and rhinovirus-associated asthma exacerbation.

[1]  T. Kawakami,et al.  Histamine-Releasing Factor Is a Novel Alarmin Induced by House Dust Mite Allergen, Cytokines, and Cell Death , 2022, The Journal of Immunology.

[2]  M. Croft,et al.  Rhinovirus Infection Promotes Eosinophilic Airway Inflammation after Prior Exposure to House Dust Mite Allergen , 2020, ImmunoHorizons.

[3]  M. Conaway,et al.  Understanding the Asthmatic Response to an Experimental Rhinovirus Infection: Exploring the Effects of Blocking IgE. , 2020, The Journal of allergy and clinical immunology.

[4]  T. Kawakami,et al.  Histamine-Releasing Factor, a New Therapeutic Target in Allergic Diseases , 2019, Cells.

[5]  Matthew C. Altman,et al.  Airway epithelium-shifted mast cell infiltration regulates asthmatic inflammation via IL-33 signaling. , 2019, The Journal of clinical investigation.

[6]  M. Grayson,et al.  Asthma and viral infections , 2019, Annals of Allergy, Asthma & Immunology.

[7]  C. Benedict,et al.  Cytomegalovirus Evades TRAIL-Mediated Innate Lymphoid Cell 1 Defenses , 2019, Journal of Virology.

[8]  T. Kawakami,et al.  Crystal structures of murine and human Histamine-Releasing Factor (HRF/TCTP) and a model for HRF dimerisation in mast cell activation , 2018, Molecular immunology.

[9]  K. Takeda,et al.  Histamine-releasing factor enhances food allergy , 2017, The Journal of clinical investigation.

[10]  T. Jartti,et al.  Role of viral infections in the development and exacerbation of asthma in children , 2017, Journal of Allergy and Clinical Immunology.

[11]  D. Davies,et al.  Mast cells are permissive for rhinovirus replication: potential implications for asthma exacerbations , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  J. Hirschhorn,et al.  Omalizumab Is Associated with Reduced Acute Severity of Rhinovirus-triggered Asthma Exacerbation. , 2016, American journal of respiratory and critical care medicine.

[13]  T. Kawakami,et al.  From IgE to Omalizumab , 2016, The Journal of Immunology.

[14]  J. Hirschhorn,et al.  Rhinovirus and serum IgE are associated with acute asthma exacerbation severity in children. , 2016, The Journal of allergy and clinical immunology.

[15]  P. Gergen,et al.  Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. , 2015, The Journal of allergy and clinical immunology.

[16]  Allan Linneberg,et al.  Respiratory allergy caused by house dust mites: What do we really know? , 2015, The Journal of allergy and clinical immunology.

[17]  J. Gern.  How rhinovirus infections cause exacerbations of asthma , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  S. Holgate.  New strategies with anti-IgE in allergic diseases , 2014, The World Allergy Organization journal.

[19]  S. Johnston,et al.  Airway Inflammation and Illness Severity in Response to Experimental Rhinovirus Infection in Asthma , 2014, Chest.

[20]  Stacy L. Gelhaus,et al.  Prostaglandin D₂ pathway upregulation: relation to asthma severity, control, and TH2 inflammation. , 2013, The Journal of allergy and clinical immunology.

[21]  H. Boushey,et al.  Asthma outcomes: exacerbations. , 2012, The Journal of allergy and clinical immunology.

[22]  M. Wabl,et al.  Sequential class switching is required for the generation of high affinity IgE antibodies , 2012, The Journal of experimental medicine.

[23]  M. Matho,et al.  Histamine-releasing factor has a proinflammatory role in mouse models of asthma and allergy. , 2012, The Journal of clinical investigation.

[24]  W. Busse,et al.  Safety of investigative bronchoscopy in the Severe Asthma Research Program. , 2011, The Journal of allergy and clinical immunology.

[25]  P. Gergen,et al.  Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. , 2011, The New England journal of medicine.

[26]  W. Busse,et al.  Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program. , 2011, American journal of respiratory and critical care medicine.

[27]  S. Johnston,et al.  The role of viruses in acute exacerbations of asthma , 2010, Journal of Allergy and Clinical Immunology.

[28]  A. Kurosky,et al.  FcγRIIb Inhibits Allergic Lung Inflammation in a Murine Model of Allergic Asthma , 2010, PloS one.

[29]  Barmak Modrek,et al.  T-helper type 2-driven inflammation defines major subphenotypes of asthma. , 2009, American journal of respiratory and critical care medicine.

[30]  D. Curran‐Everett,et al.  Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.

[31]  A. James,et al.  Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma , 2002, Thorax.

[32]  I. Pavord,et al.  Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.

[33]  B. Ferris,et al.  Epidemiology Standardization Project (American Thoracic Society). , 1978, The American review of respiratory disease.

[34]  S. Spector,et al.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. , 2000, American journal of respiratory and critical care medicine.